AG019FVO

3521-62-8 | Erythromycin, 2'-​propanoate, dodecyl sulfate (1:1)

Chemical structure of Erythromycin, 2'-​propanoate, dodecyl sulfate (1:1), CAS 3521-62-8
AG019FVO
sdsSDS
sdsCOA

Price

$0.00

WARNING This product is not for human or veterinary use.
Request For Quotation
CAS Number 3521-62-8
Catalog Number AG019FVO(AGN-PC-0RAL8A)
Chemical Name Erythromycin, 2'-​propanoate, dodecyl sulfate (1:1)
EC Number 222-532-4
IUPAC Name [(2S,3R,4S,6R)-4-(dimethylamino)-2-[[(3R,4S,5S,6R,7R,9R,11R,12R,13S,14R)-14-ethyl-7,12,13-trihydroxy-4-[(2R,4R,5S,6S)-5-hydroxy-4-methoxy-4,6-dimethyloxan-2-yl]oxy-3,5,7,9,11,13-hexamethyl-2,10-dioxo-oxacyclotetradec-6-yl]oxy]-6-methyloxan-3-yl] propanoate;dodecyl hydrogen sulfate
InChI InChI=1S/C40H71NO14.C12H26O4S/c1-15-27-40(11,48)33(44)22(5)30(43)20(3)18-38(9,47)35(55-37-32(53-28(42)16-2)26(41(12)13)17-21(4)50-37)23(6)31(24(7)36(46)52-27)54-29-19-39(10,49-14)34(45)25(8)51-29;1-2-3-4-5-6-7-8-9-10-11-12-16-17(13,14)15/h20-27,29,31-35,37,44-45,47-48H,15-19H2,1-14H3;2-12H2,1H3,(H,13,14,15)/t20-,21-,22+,23+,24-,25+,26+,27-,29+,31+,32-,33-,34+,35-,37+,38-,39-,40-;/m1./s1
InChI Key AWMFUEJKWXESNL-JZBHMOKNSA-N
MDL Number MFCD00084691
Molecular Formula C49H93NO17S
Molecular Weight 1000.3242
NSC Number 757880
SMILES CCC1OC(=O)[C@@H](C)[C@H](O[C@@H]2O[C@@H](C)[C@@H]([C@](C2)(C)OC)O)[C@@H](C)[C@H](O[C@@H]2O[C@H](C)C[C@@H]([C@H]2O)N(C)C)[C@@](C[C@@H](C(=O)C([C@H](C1(C)O)O)C)C)(C)O.CCCCCCCCCCCCOS(=O)(=O)O
UNII XRJ2P631HP
Synonyms
Eromycin, Erythromycin Estolate, Erythromycin Propionate Dodecyl Sulfate, Erythromycin Propionate Lauryl Sulfate, Erythromycin Propionate Monododecyl Sulfate, Estolate, Erythromycin, Ilosone, Lauromicina, ERYTHROMYCIN ESTOLATE, Eritroger, Lubomycine B, erythromycin propionate lauryl sulfate, 3521-62-8, UNII-XRJ2P631HP, Lauromicina, Marcoeritrex, Stellamicina, Biomicron, Eriscel, Eromycin, Estomicina, Ilosone, Roxomicina, Erythromycin estorate, Neo-erycinum, Erythromycin propionyl laurylsulfate, PELS, Erythromycin 2'-propionate dodecyl sulfate (salt), XRJ2P631HP, Prospiocine, Erytrarco, CHEBI:4846, Ery-Toxinal dodecylsulfate, Erythromycinestolate, Erythromycine estolate, Propionylerythromycin lauryl sulfate, Lauryl sulfate propionyl erythromycin ester, Erythromycin propionate dodecylsulfate (salt), Erythromycin 5-(3-propionate) dodecyl sulfate, EINECS 222-532-4, Erythromycin propionate, compound with dodecyl sulfate, NSC 263364, Erythromycin propionate, compd. with dodecyl sulfate, Erythromycin, 2'-propanoate, dodecyl sulfate (salt), Erythromycin, propionate (ester), compd. with monododecyl sulfate, Propionic acid, 2'-ester with erythromycin, dodecyl sulfate salt, Sulfuric acid, monododecyl ester, compd. with erythromycin 2'-propionate (1:1), Erythromycin estolate [USAN:USP:BAN:JAN], AC1L9B1V, SCHEMBL3331, DSSTox_CID_17224, DSSTox_RID_79309, DSSTox_GSID_37224, Erythromycin estolate (USP), Erythromycin estorate (JAN), SPECTRUM1501176, CHEMBL2218877, DTXSID1037224, Erythromycin, propionate (ester), compd. with monododecyl sulfate (1:1), BDBM31688, HMS500A11, Sulfuric acid, monododecyl ester, compd. with erythromycin 2'-propanoate (1:1), HMS1921N13, HMS2092J15, Pharmakon1600-01501176, Tox21_302229, CCG-38968, LMPK04000015, MFCD00084691, NSC757880, monopropionylerythromycin laurylsulfate, AKOS015896121, NSC-757880, NCGC00180881-01, NCGC00255571-01, CC-27518, CAS-3521-62-8, Erythromycin 2''-propionate dodecyl sulfate, PROPIONYL ERYTHROMYCIN LAURYL SULFATE, ERYTHROMYCIN LAURYL SULFATE, PROPIONYL, C08031, D00851, Erythromycin 2'-propanoate Dodecyl Sulfate Salt, 521E628, C-23603, Erythromycin propionate compd. with dodecyl sulfate, SR-05000002085, Erythromycin propionate compound with dodecyl sulfate, I06-1630, Q-201066, SR-05000002085-1, Erythromycin 2'-propionate monododecyl sulfate (salt), propionic acid, 2'-ester with erythromycin, dodecyl sulfate, Erythromycin, 2'-propionate, monododecyl sulfate (salt) (8CI), Erythromycin propionate (ester) compd. with monododecyl sulfate (1:1), Sulfuric acid monododecyl ester compd. with erythromycin 2'-propionate (1:1), (3R,4S,5S,6R,7R,9R,11R,12R,13S,14R)-4-(2,6-dideoxy-3-C-methyl-3-O-methyl-alpha-L-ribo-hexopyranosyloxy)-14-ethyl-7,12,13-trihydroxy-6-[3,4,6-trideoxy-3-(dimethylamino)-2-O-propanoyl-beta-D-xylo-hexopyranosyloxy]-3,5,7,9,11,13-hexamethyloxacyclotetradecane-2,10-dione dodecyl hydrogen sulfate, [(2S,3R,4S,6R)-4-(dimethylamino)-2-[[(3R,4S,5S,6R,7R,9R,11R,12R,13S,14R)-14-ethyl-7,12,13-trihydroxy-4-[(2R,4R,5S,6S)-5-hydroxy-4-methoxy-4,6-dimethyloxan-2-yl]oxy-3,5,7,9,11,13-hexamethyl-2,10-dioxo-oxacyclotetradec-6-yl]oxy]-6-methyloxan-3-yl] propanoate; dodecyl hydrogen sulfate, Ilosone (TN), CID441371, ACN-037188, C40H71NO14.C12H26O4S, Erythromycin estolate [USAN:BAN:JAN], C40-H71-N-O14.C12-H26-O4-S, Eritromicina, 2'-propanoato, dodecil sulfato (1:1), Erythromycin, 2'-propionate, monododecyl sulfate (salt),

Related Research Chemicals

CERTIFICATE OF ANALYSIS
Chemical Name: Batch Number:
Chemical Structure: CAS Registry No:
Product ID:
Manufacture Date:
Storage Temperature:
Formula:
Molecular Weight:
Quantity:
Analysis Data:
Test: Result:
Conclusion: The above product meets the specifications of Angene.
Analyst:Chase
Date:
Reviewed by:Jessie
Date:
Angene International Limited